Bardzo tanie apteki z dostawą w całej Polsce kupic cialis i ogromny wybór pigułek.

2-15900.pdf

CAFFEINE
1. Chemical Product And Company Identification

Company's Name: REAGENTS, INC.
Company's P. O. Box: 240746
Company's City: CHARLOTTE
Company's State: NC
Company's Country: US
Company's Zip Code: 28224
Company's Info Ph #: 704/554-7474, 800/732-8484
Date MSDS Prepared: April 16, 2003
Synonyms: 1,3,7-trimethylxanthine
CAS No.: 58-08-2
Molecular Weight: 194.19
Chemical Formula: C8H10N4O2
Product Codes: 2-15900


2. Composition/Information on Ingredients

Ingredient CAS No Percent Hazardous
--------------------------------------- ------------ ------- ---------
Caffeine 58-08-2 100% Yes


3. Hazards Identification
Emergency Overview

--------------------------
WARNING! HARMFUL IF SWALLOWED OR INHALED. CAUSES IRRITATION TO SKIN,
EYES AND RESPIRATORY TRACT. POSSIBLE BIRTH DEFECT HAZARD. MAY CAUSE
BIRTH DEFECTS BASED ON ANIMAL DATA.

-----------------------------------------------------------------------------------------------------------
Health Rating: 2 - Moderate
Flammability Rating: 1 - Slight
Reactivity Rating: 0 - None
Contact Rating: 1 - Slight
Lab Protective Equip: GOGGLES; LAB COAT
Storage Color Code: Green (General Storage)
-----------------------------------------------------------------------------------------------------------
Potential Health Effects
----------------------------------
Inhalation: Inhalation of dust may irritate the mucous membranes and respiratory tract. High

concentrations may produce effects paralleling ingestion.
Ingestion: Toxic. The adult mean lethal dose is approximately 10 gm. Large doses may produce
palpitation, excitement, insomnia, dizziness, headache and vomiting.
Skin Contact: Causes irritation to skin. Symptoms include redness, itching, and pain.
Eye Contact: Causes irritation, redness, and pain.
Chronic Exposure: Excessive use of caffeine may lead to digestive disturbances, constipation,
palpitations, shortness of breath and depressed mental states. Possible teratogen. May cause congenital
malformation in the fetus.
Aggravation of Pre-existing Conditions: No information found.


4. First Aid Measures
Inhalation:
Remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give
oxygen. Get medical attention.
Ingestion: Induce vomiting immediately as directed by medical personnel. Never give anything by
mouth to an unconscious person. Get medical attention.
Skin Contact: Immediately flush skin with plenty of water for at least 15 minutes. Remove
contaminated clothing and shoes. Get medical attention. Wash clothing before reuse. Thoroughly clean
shoes before reuse.
Eye Contact: Immediately flush eyes with plenty of water for at least 15 minutes, lifting lower and upper
eyelids occasionally. Get medical attention immediately.


5. Fire Fighting Measures
Fire:
As with most organic solids, fire is possible at elevated temperatures or by contact with an ignition
source.
Explosion: Fine dust dispersed in air in sufficient concentrations, and in the presence of an ignition
source is a potential dust explosion hazard.
Fire Extinguishing Media: Water spray, dry chemical, alcohol foam, or carbon dioxide.
Special Information: In the event of a fire, wear full protective clothing and NIOSH-approved self-
contained breathing apparatus with full-facepiece operated in the pressure demand or other positive
pressure mode.


6. Accidental Release Measures

Remove all sources of ignition. Ventilate area of leak or spill. Wear appropriate personal protective
equipment as specified in Section 8. Spills: Clean up spills in a manner that does not disperse dust into
the air. Use non-sparking tools and equipment. Reduce airborne dust and prevent scattering by
moistening with water. Pick up spill for recovery or disposal and place in a closed container.


7. Handling and Storage
Keep in a tightly closed container, stored in a cool, dry, ventilated area. Protect against physical
damage. Containers of this material may be hazardous when empty since they retain product residues
(dust, solids); observe all warnings and precautions listed for the product.



8. Exposure Controls/Personal Protection
Airborne Exposure Limits:
None established.
Ventilation System: A system of local and/or general exhaust is recommended to keep employee
exposures as low as possible. Local exhaust ventilation is generally preferred because it can control the
emissions of the contaminant at its source, preventing dispersion of it into the general work area. Please
refer to the ACGIH document, Industrial Ventilation, A Manual of Recommended Practices, most recent
edition, for details.
Personal Respirators (NIOSH Approved): For conditions of use where exposure to the dust or mist is
apparent, a half-face dust/mist respirator may be worn. For emergencies or instances where the
exposure levels are not known, use a full-face positive-pressure, air-supplied respirator. WARNING: Air-
purifying respirators do not protect workers in oxygen-deficient atmospheres.
Skin Protection: Wear impervious protective clothing, including boots, gloves, lab coat, apron or
coveralls, as appropriate, to prevent skin contact.
Eye Protection: Use chemical safety goggles and/or full face shield where dusting or splashing of
solutions is possible. Maintain eye wash fountain and quick-drench facilities in work area.


9. Physical and Chemical Properties
Appearance:
White powder.
Odor: Odorless.
Solubility: 1 gm in 46 mls water.
Specific Gravity: 1.23
pH: 6.9 (1% aqueous solution)
% Volatiles by volume @ 21oC (70oF): 0
Boiling Point: 178oC (352oF) (sublimes)
Melting Point: 238oC (460oF)
Vapor Density (Air=1): No information found.
Vapor Pressure (mm Hg): No information found.
Evaporation Rate (BuAc=1): No information found.


10. Stability and Reactivity
Stability:
Stable under ordinary conditions of use and storage.
Hazardous Decomposition Products: Burning may produce carbon monoxide, carbon dioxide, nitrogen
oxides.
Hazardous Polymerization: Will not occur.
Incompatibilities: Incompatible with strong oxidizers, iodine silver salts, tannins, and with strong
solutions of caustic alkalis.
Conditions to Avoid: Heat, flames, ignition sources and incompatibles.



11. Toxicological Information
Toxicological Data:
Oral rat LD50: 192 mg/kg. Investigated as a tumorigen, mutagen, reproductive
effector.
Reproductive Toxicity: May cause teratogenic effects.
--------\Cancer Lists\------------------------------------------------------

Ingredient Known Anticipated IARC Category ------------------------------------ ----- ----------- ------------- Caffeine (58-08-2) No No 3
12. Ecological Information
Environmental Fate:
When released into the soil, this material may biodegrade to a moderate extent.
When released into water, this material may biodegrade to a moderate extent. This material is not
expected to significantly bioaccumulate.
Environmental Toxicity: No information found.


13. Disposal Considerations

Whatever cannot be saved for recovery or recycling should be managed in an appropriate and approved
waste disposal facility. Processing, use or contamination of this product may change the waste
management options. State and local disposal regulations may differ from federal disposal regulations.
Dispose of container and unused contents in accordance with federal, state and local requirements.


14. Transport Information
Domestic (Land, D.O.T.)

-----------------------
Proper Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.(CAFFEINE)
Hazard Class: 6.1
UN/NA: UN2811
Packing Group: III
International (Water, I.M.O.)
-----------------------------
Proper Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.(CAFFEINE)
Hazard Class: 6.1

UN/NA: UN2811
Packing Group: III
International (Air, I.C.A.O.)
-----------------------------
Proper Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.(CAFFEINE)
Hazard Class: 6.1
UN/NA: UN2811
Packing Group: III


15. Regulatory Information

--------\Chemical Inventory Status - Part 1\---------------------------------
Ingredient TSCA EC Japan Australia
----------------------------------------------- ---- --- ----- ---------
Caffeine (58-08-2) Yes Yes Yes Yes
--------\Chemical Inventory Status - Part 2\---------------------------------

Ingredient Korea DSL NDSL Phil. ----------------------------------------------- ----- --- ---- ----- Caffeine (58-08-2) Yes Yes No Yes --------\Federal, State & International Regulations - Part 1\---------------- Ingredient RQ TPQ List Chemical Catg. ----------------------------------------- --- ----- ---- -------------- Caffeine (58-08-2) No No No No --------\Federal, State & International Regulations - Part 2\---------------- Ingredient CERCLA 261.33 8(d)
----------------------------------------- ------ ------ ------
Caffeine (58-08-2) No No No
Chemical Weapons Convention: No TSCA 12(b): No CDTA: No
SARA 311/312: Acute: Yes Chronic: Yes Fire: No Pressure: No
Reactivity: No (Pure / Solid)
WHMIS: This MSDS has been prepared according to the hazard criteria of the Controlled Products
Regulations (CPR) and the MSDS contains all of the information required by the CPR.


16. Other Information

NFPA Ratings: Health: 2 Flammability: 1 Reactivity: 0
Label Hazard Warning: WARNING! HARMFUL IF SWALLOWED OR INHALED. CAUSES
IRRITATION TO SKIN, EYES AND RESPIRATORY TRACT. POSSIBLE BIRTH DEFECT HAZARD.
MAY CAUSE BIRTH DEFECTS BASED ON ANIMAL DATA.
Label Precautions:
Avoid contact with eyes, skin and clothing.
Avoid breathing dust.
Keep container closed.
Use only with adequate ventilation.
Wash thoroughly after handling.
Label First Aid: In case of contact, immediately flush eyes or skin with plenty of water for at least 15
minutes. Remove contaminated clothing and shoes. Wash clothing before reuse. If inhaled, remove to
fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. If swallowed,
induce vomiting immediately as directed by medical personnel. Never give anything by mouth to an
unconscious person. In all cases, get medical attention.
Product Use: Laboratory Reagent.
Disclaimer:
************************************************************************************
Reagents, Inc. provides the information contained herein in good faith but makes no representation
as to its comprehensiveness or accuracy. This document is intended only as a guide to the
appropriate precautionary handling of the material by a properly trained person using this product.
Individuals receiving the information must exercise their independent judgment in determining its
appropriateness for a particular purpose. REAGENTS, INC. MAKES NO REPRESENTATIONS
OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION
ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE
WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT TO
WHICH THE INFORMATION REFERS. ACCORDINGLY, REAGENTS, INC. WILL NOT BE
RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF OR RELIANCE UPON THIS
INFORMATION.

************************************************************************************

Source: http://www.reagents.com/pdf/msds/2-15900.pdf

jscva.org

1. How does EuroSCORE II perform in UK cardiac surgery; an analysis of 23,740 patients from the Society for Cardiothoracic Surgery in Great Britain and Ireland National Database. Heart 2012 Aug 21. PMID: 22914533 2. Prognostic implications of preoperative E/e' ratio in patients with off-pump coronary artery surgery. Anesthesiology 2012; 116:362-71. PMID: 22222471. 3. Time course and prognostic

Quietfield ltd -v- cascroft contractors ltd

PDF Judgment from adjudication.co.uk Neutral Citation Number: [2006] EWHC 174 (TCC) IN THE HIGH COURT OF JUSTICE QUEEN'S BENCH DIVISION TECHNOLOGY AND CONSTRUCTION COURT MR. JUSTICE JACKSON - - - - - - - - - - - - - - - - - - - - - Between: QUIETFIELD Claimant VASCROFT CONTRACTORS Defendant - - - - - - - - - - - - - - - - - - - - - Tape Transcription

Copyright © 2010-2014 Medical Articles